Handelsavisen
prelaunch
Companies Financials 0966.HK
09
0966.HK HKEX Life & Health Insurance

China Taiping Insurance Holdings Co Ltd

HK$20,82
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
5,52 %
Op margin
ROE
24,3 %
Net margin
Debt / equity
0,71
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

China Taiping Insurance Holdings Co Ltd provides life and health insurance products and services in China and internationally, generating revenue primarily through premium income and investment returns.

Business. China Taiping Insurance Holdings Co Ltd (0966.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not provided.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryLife & Health Insurance
Generated · model-assisted
Sell-side consensus
BUY12 analysts
9 buy3 hold0 sell
Avg 12m price target25,78

Analyst recommendations

12 analysts · consensus Buy
Buy9
Hold3
Sell0
12-month price target
25,78
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
12 analysts · indicative
Ownership
not yet wired
Profitability
24,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 0966.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 0966.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    China Taiping Insurance Holdings Co Ltd (0966.HK) is a life and health insurance company headquartered in China. The firm operates within the Financials sector, specifically focusing on the Life & Health Insurance industry. It is primarily listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryLife & Health Insurance
    AI synthesis
    GENERATED

    China Taiping's capital structure is characterized by a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. The company maintains a liquidity position of medium risk, with free cash flow of 32.08 billion HKD and operating cash flow of 108.83 billion HKD, but its cash and equivalents of 9.75 billion HKD are insufficient to cover its long-term debt of 78.94 billion HKD. This suggests a need for ongoing cash flow generation to service obligations.

    Profitability metrics show a return on equity (ROE) of 24.35%, which is strong, but the return on assets (ROA) of 1.36% is relatively low for an insurance company, indicating that the company is not efficiently utilizing its asset base to generate returns. This discrepancy may reflect the capital-intensive nature of the insurance industry and the company's investment strategy.

    Geographically, China Taiping's revenue is heavily concentrated in China, with limited exposure to international markets. The company's business is primarily driven by its domestic operations, which exposes it to regulatory and economic risks specific to the Chinese market. There is no detailed breakdown of segment performance in the available data, but the company's primary revenue source is its life and health insurance offerings.

    The company's growth trajectory is expected to remain stable, with no significant changes in revenue or earnings projected in the next fiscal year. Analysts have assigned a mean price target of 25.78 HKD, with a median of 25.70 HKD, and a mean recommendation of 1.92, indicating a generally positive outlook. However, the absence of a clear growth driver beyond its core insurance operations suggests that expansion may be limited without strategic acquisitions or new product development.

    Risk factors include liquidity concerns due to the company's negative net cash position after subtracting total debt. The risk assessment also highlights the potential for dilution, though it is currently rated as low. The company has not issued additional shares recently, and there is no indication of imminent dilution pressure. However, the company's capital structure and reliance on debt financing could expose it to interest rate and credit risk.

    Recent events include the publication of the latest financial data, which shows a net income of 27.06 billion HKD and operating income of 33.86 billion HKD. There are no recent filings or transcripts indicating significant changes in strategy or operations. The company's performance appears to be in line with industry expectations, with no major deviations in its financial or operational metrics.

    Key takeaways
    • China Taiping maintains a strong ROE of 24.35% but a weak ROA of 1.36%, suggesting inefficiencies in asset utilization.
    • The company's liquidity position is medium risk, with free cash flow of 32.08 billion HKD but insufficient cash to cover long-term debt.
    • Revenue is heavily concentrated in China, exposing the company to domestic regulatory and economic risks.
    • Analysts project a stable outlook with a mean price target of 25.78 HKD and a generally positive recommendation score.
    • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.71.
    • There is no immediate dilution risk, but the company's negative net cash position after debt raises liquidity concerns.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$20,82
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    HK$111.14B
    Net cash
    -HK$69.19B
    Current ratio
    Debt / equity
    0.7
    ROA
    1.4%
    ROE
    24.3%
    Cash conversion
    402.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    3,67
    Predicted surprise
    0,00
    Beat probability
    45 %
    Analysts
    12
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-20 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate3,67
    Revenueno estimateno estimate117,0B HKD
    Operating incomeno estimateno estimate43,3B HKD
    Full-year consensus mean (period as reported by source) · consensus in HKD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution12 analysts
    Strong buy4
    Buy5
    Hold3
    Sell0
    Strong sell0
    12-month price targetHK$25,78 · Median HK$25,70
    Low HK$21,00High HK$33,10
    Operating income · consensus43,3B HKD
    EPS surprise
    +97,8 %
    reported vs consensus · beat
    Revenue surprise
    −4,0 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowHK$21,00
    MeanHK$25,78
    MedianHK$25,70
    HighHK$33,10
    SpotHK$20,82
    +23.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE24,3 %Best in class
    D/E0,71Bottom quartile
    Cash Conv4,02Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • China Taiping Insurance Holdings Co Ltd Market data — financials · 2026-05-26
    • China Taiping Insurance Holdings Co Ltd Market data — analyst estimates · 2026-05-26
    • China Taiping Insurance Holdings Co Ltd Market data — ESG · 2026-05-26

    Ownership & reference

    Leadership

    • Sidong WangExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    0966.HKCanonical
    HKEX · HKD

    Intel & risk

    PredictorBeat prob45 %Surprise0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage